The Patent Finder

Terms ending in 2034

Ucb Pharma S.A.

Every in-force patent on Ucb Pharma S.A.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,757,524Auto-Injector
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 9,757,521Auto-Injector
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 9,764,101Auto-Injector
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 9,757,513Auto-Injector
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 11,896,667Treatment for Bone Diseases
In force
 · Medium confidence
Ucb Pharma, S.A.In forceMedium confidence
US 9,630,948Compounds for Enhancing the Cognitive Function
In force
 · High confidence
Ucb Biopharma SRLIn forceHigh confidence
US 10,258,740Auto-Injector
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited